Artículos de revistas sobre el tema "HDAC 3"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "HDAC 3".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Bertos, Nicholas R., Audrey H. Wang y Xiang-Jiao Yang. "Class II histone deacetylases: Structure, function, and regulation". Biochemistry and Cell Biology 79, n.º 3 (1 de junio de 2001): 243–52. http://dx.doi.org/10.1139/o01-032.
Texto completoOzawa, Yukiyasu, Masayuki Towatari, Shinobu Tsuzuki, Fumihiko Hayakawa, Takahiro Maeda, Yasuhiko Miyata, Mitsune Tanimoto y Hidehiko Saito. "Histone deacetylase 3 associates with and represses the transcription factor GATA-2". Blood 98, n.º 7 (1 de octubre de 2001): 2116–23. http://dx.doi.org/10.1182/blood.v98.7.2116.
Texto completoStubbs, Matthew C., Won-Il Kim, Tina Davis, Jun Qi, James Bradner, Andrew L. Kung y Scott A. Armstrong. "Selective Inhibition of HDAC1 and HDAC2 Is a Potential Therapeutic Option for B-All". Blood 116, n.º 21 (19 de noviembre de 2010): 2900. http://dx.doi.org/10.1182/blood.v116.21.2900.2900.
Texto completoVarricchio, Lilian, Carmela Dell'Aversana, Angela Nebbioso, Giovanni Migliaccio, Lucia Altucci, James J. Bieker y Anna Rita F. Migliaccio. "Identification of a New Functional HDAC Complex Composed by HDAC5, GATA1 and EKLF in Human Erythroid Cells". Blood 120, n.º 21 (16 de noviembre de 2012): 979. http://dx.doi.org/10.1182/blood.v120.21.979.979.
Texto completoMigliaccio, Giovanni, Carmela Dell’Aversana, Angela Nebbioso, Elena Alfani, Lilian arricchio, Antonello Mai, Pratima Chaurasia et al. "Ontogenic-Specific Increasesin HDAC1 Activity and Transcription Factor Association During the Maturation of Human Adult Erythroblasts in Vitro." Blood 114, n.º 22 (1 de noviembre de 2009): 1978. http://dx.doi.org/10.1182/blood.v114.22.1978.1978.
Texto completoHess, Lena, Verena Moos, Arnel A. Lauber, Wolfgang Reiter, Michael Schuster, Natascha Hartl, Daniel Lackner et al. "A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation". PLOS Genetics 18, n.º 8 (22 de agosto de 2022): e1010376. http://dx.doi.org/10.1371/journal.pgen.1010376.
Texto completoKeedy, Kara S., Nancie M. Archin, Adam T. Gates, Amy Espeseth, Daria J. Hazuda y David M. Margolis. "A Limited Group of Class I Histone Deacetylases Acts To Repress Human Immunodeficiency Virus Type 1 Expression". Journal of Virology 83, n.º 10 (11 de marzo de 2009): 4749–56. http://dx.doi.org/10.1128/jvi.02585-08.
Texto completoMasselli, Elena, Lilian Varricchio, Barbara Ghinassi, Carolyn Whitsett, Patricia A. Shi y Anna Rita F. Migliaccio. "Class IIa HDAC Inhibitors Reduce HDAC1 Activity by off-Target Effects Which Reduce GATA1 Expression In Human Erythroblasts Expanded Ex-Vivo". Blood 116, n.º 21 (19 de noviembre de 2010): 4780. http://dx.doi.org/10.1182/blood.v116.21.4780.4780.
Texto completoIbrahim, Hany S., Mohamed Abdelsalam, Yanira Zeyn, Matthes Zessin, Al-Hassan M. Mustafa, Marten A. Fischer, Patrik Zeyen et al. "Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity". International Journal of Molecular Sciences 23, n.º 1 (29 de diciembre de 2021): 369. http://dx.doi.org/10.3390/ijms23010369.
Texto completoAngiolilli, Chiara, Pawel A. Kabala, Aleksander M. Grabiec, Iris M. Van Baarsen, Bradley S. Ferguson, Samuel García, Beatriz Malvar Fernandez et al. "Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes". Annals of the Rheumatic Diseases 76, n.º 1 (25 de julio de 2016): 277–85. http://dx.doi.org/10.1136/annrheumdis-2015-209064.
Texto completoIhlefeld, Katja, Ralf Frederik Claas, Alexander Koch, Josef M. Pfeilschifter y Dagmar Meyer zu Heringdorf. "Evidence for a link between histone deacetylation and Ca2+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts". Biochemical Journal 447, n.º 3 (5 de octubre de 2012): 457–64. http://dx.doi.org/10.1042/bj20120811.
Texto completoBaumann, Philipp, Carmen Junghanns, Strobl Stefan, Fuat Oduncu y Ralf Schmidmaier. "The Novel Pan-HDAC Inhibitor CR2408 Inhibits Multiple Myeloma Cell Growth and Proliferation". Blood 118, n.º 21 (18 de noviembre de 2011): 5133. http://dx.doi.org/10.1182/blood.v118.21.5133.5133.
Texto completoMcKinsey, Timothy A., Chun Li Zhang y Eric N. Olson. "Identification of a Signal-Responsive Nuclear Export Sequence in Class II Histone Deacetylases". Molecular and Cellular Biology 21, n.º 18 (15 de septiembre de 2001): 6312–21. http://dx.doi.org/10.1128/mcb.21.18.6312-6321.2001.
Texto completoKim, Jwa-Young, Hae-Yong Kweon, Dae-Won Kim, Je-Yong Choi y Seong-Gon Kim. "4-Hexylresorcinol Inhibits Class I Histone Deacetylases in Human Umbilical Cord Endothelial Cells". Applied Sciences 11, n.º 8 (13 de abril de 2021): 3486. http://dx.doi.org/10.3390/app11083486.
Texto completoXiao, Yufeng, Seth Hale, Nikee Awasthee, Xuan Zhang, Yi Liu, Zhiguang Huo, Dongwen Lyu et al. "Abstract 5347: Selective targeting deacetylase 3 (HDAC3) and HDAC8 by PROTACs". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 5347. http://dx.doi.org/10.1158/1538-7445.am2023-5347.
Texto completoLaschanzky, Richard S., Lisa E. Humphrey, Jihyun Ma, Lynette M. Smith, Thomas J. Enke, Surendra K. Shukla, Aneesha Dasgupta et al. "Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer Therapy". Cancers 11, n.º 9 (7 de septiembre de 2019): 1327. http://dx.doi.org/10.3390/cancers11091327.
Texto completoGrégoire, Serge, Lin Xiao, Jianyun Nie, Xiaohong Zhang, Minghong Xu, Jiarong Li, Jiemin Wong, Edward Seto y Xiang-Jiao Yang. "Histone Deacetylase 3 Interacts with and Deacetylates Myocyte Enhancer Factor 2". Molecular and Cellular Biology 27, n.º 4 (11 de diciembre de 2006): 1280–95. http://dx.doi.org/10.1128/mcb.00882-06.
Texto completoHeppt, Markus V., Anja Wessely, Eva Hornig, Claudia Kammerbauer, Saskia A. Graf, Robert Besch, Lars E. French et al. "HDAC2 Is Involved in the Regulation of BRN3A in Melanocytes and Melanoma". International Journal of Molecular Sciences 23, n.º 2 (13 de enero de 2022): 849. http://dx.doi.org/10.3390/ijms23020849.
Texto completoTurgeon, Naomie, Julie Moore Gagné, Mylène Blais, Fernand-Pierre Gendron, François Boudreau y Claude Asselin. "The acetylome regulators Hdac1 and Hdac2 differently modulate intestinal epithelial cell dependent homeostatic responses in experimental colitis". American Journal of Physiology-Gastrointestinal and Liver Physiology 306, n.º 7 (1 de abril de 2014): G594—G605. http://dx.doi.org/10.1152/ajpgi.00393.2013.
Texto completoGuise, Amanda J., Todd M. Greco, Irene Y. Zhang, Fang Yu y Ileana M. Cristea. "Aurora B-dependent Regulation of Class IIa Histone Deacetylases by Mitotic Nuclear Localization Signal Phosphorylation". Molecular & Cellular Proteomics 11, n.º 11 (2 de agosto de 2012): 1220–29. http://dx.doi.org/10.1074/mcp.m112.021030.
Texto completoHan, Ying, Le Chen, Jingyun Liu, Jie Chen, Chunyang Wang, Yu Guo, Xuebin Yu, Chenghong Zhang, Haiying Chu y Haiying Ma. "A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway". Molecules 27, n.º 13 (29 de junio de 2022): 4160. http://dx.doi.org/10.3390/molecules27134160.
Texto completoKraft, Fabian B., Maria Hanl, Felix Feller, Linda Schäker-Hübner y Finn K. Hansen. "Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy". Pharmaceuticals 16, n.º 3 (25 de febrero de 2023): 356. http://dx.doi.org/10.3390/ph16030356.
Texto completoLewis, A., B. Pan-Castillo, G. Berti, C. Felice, H. Gordon, R. Gadhok, A. Minicozzi et al. "DOP23 Single-cell RNA sequencing identifies an important role for class I histone-deacetylase enzymes in intestinal myofibroblasts from patients with Crohn’s Disease strictures". Journal of Crohn's and Colitis 15, Supplement_1 (1 de mayo de 2021): S062. http://dx.doi.org/10.1093/ecco-jcc/jjab073.062.
Texto completoAriffin, Juliana K., Kaustav das Gupta, Ronan Kapetanovic, Abishek Iyer, Robert C. Reid, David P. Fairlie y Matthew J. Sweet. "Histone Deacetylase Inhibitors Promote Mitochondrial Reactive Oxygen Species Production and Bacterial Clearance by Human Macrophages". Antimicrobial Agents and Chemotherapy 60, n.º 3 (28 de diciembre de 2015): 1521–29. http://dx.doi.org/10.1128/aac.01876-15.
Texto completoGuenther, Matthew G., Orr Barak y Mitchell A. Lazar. "The SMRT and N-CoR Corepressors Are Activating Cofactors for Histone Deacetylase 3". Molecular and Cellular Biology 21, n.º 18 (15 de septiembre de 2001): 6091–101. http://dx.doi.org/10.1128/mcb.21.18.6091-6101.2001.
Texto completoCao, Biyin, Mingyun Shen, Depei Wu, Jianhong Du, Jingyu Zhu, Suning Chen, Aining Sun et al. "The Proteasomal Inhibitor Clioquinol Induces Apoptosis in Leukemia and Myeloma Cells by Inhibiting Histone Deacetylase Activity." Blood 120, n.º 21 (16 de noviembre de 2012): 2449. http://dx.doi.org/10.1182/blood.v120.21.2449.2449.
Texto completoKim, Min Young, Bowen Yan, Suming Huang y Yi Qiu. "Regulating the Regulators: The Role of Histone Deacetylase 1 (HDAC1) in Erythropoiesis". International Journal of Molecular Sciences 21, n.º 22 (11 de noviembre de 2020): 8460. http://dx.doi.org/10.3390/ijms21228460.
Texto completoTang, Jinhua, Yanli Yan, Ting C. Zhao, George Bayliss, Haidong Yan y Shougang Zhuang. "Class I histone deacetylase activity is required for proliferation of renal epithelial cells". American Journal of Physiology-Renal Physiology 305, n.º 3 (1 de agosto de 2013): F244—F254. http://dx.doi.org/10.1152/ajprenal.00126.2013.
Texto completoMoreth, Kristin, Daniel Riester, Christian Hildmann, René Hempel, Dennis Wegener, Andreas Schober y Andreas Schwienhorst. "An active site tyrosine residue is essential for amidohydrolase but not for esterase activity of a class 2 histone deacetylase-like bacterial enzyme". Biochemical Journal 401, n.º 3 (12 de enero de 2007): 659–65. http://dx.doi.org/10.1042/bj20061239.
Texto completoHamoud, Mohamed M. S., Sravani Pulya, Nermine A. Osman, Yamini Bobde, Abdalla E. A. Hassan, Hanan A. Abdel-Fattah, Balaram Ghosh y Amany M. Ghanim. "Design, synthesis, and biological evaluation of novel nicotinamide derivatives as potential histone deacetylase-3 inhibitors". New Journal of Chemistry 44, n.º 23 (2020): 9671–83. http://dx.doi.org/10.1039/d0nj01274b.
Texto completoWeiss, Ulrike, Moritz Möller, Sayed Adham Husseini, Christine Manderscheid, Julia Häusler, Gerd Geisslinger y Ellen Niederberger. "Inhibition of HDAC Enzymes Contributes to Differential Expression of Pro-Inflammatory Proteins in the TLR-4 Signaling Cascade". International Journal of Molecular Sciences 21, n.º 23 (25 de noviembre de 2020): 8943. http://dx.doi.org/10.3390/ijms21238943.
Texto completoDing, Jianming (Diane), Masaki Ri, Tomoko Narita, Ayako Masaki, Fumiko Mori, Asahi Ito, Shigeru Kusumoto et al. "Reduced Expression of HDAC3 Contributes to the Resistance Against HDAC Inhibitor, Vorinostat (SAHA) in Mature Lymphoid Malignancies". Blood 120, n.º 21 (16 de noviembre de 2012): 1342. http://dx.doi.org/10.1182/blood.v120.21.1342.1342.
Texto completoDi Giorgio, Eros, Andrea Clocchiatti, Sara Piccinin, Andrea Sgorbissa, Giulia Viviani, Paolo Peruzzo, Salvatore Romeo et al. "MEF2 Is a Converging Hub for Histone Deacetylase 4 and Phosphatidylinositol 3-Kinase/Akt-Induced Transformation". Molecular and Cellular Biology 33, n.º 22 (16 de septiembre de 2013): 4473–91. http://dx.doi.org/10.1128/mcb.01050-13.
Texto completoElbatrawy, Omnia R., Mohamed Hagras, Moshira A. El Deeb, Fatimah Agili, Maghawry Hegazy, Ahmed A. El-Husseiny, Mahmoud Mohamed Mokhtar, Samy Y. Elkhawaga, Ibrahim H. Eissa y Samar El-Kalyoubi. "Discovery of New Uracil and Thiouracil Derivatives as Potential HDAC Inhibitors". Pharmaceuticals 16, n.º 7 (6 de julio de 2023): 966. http://dx.doi.org/10.3390/ph16070966.
Texto completoLuo, Yuxiang y Huilin Li. "Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)". International Journal of Molecular Sciences 21, n.º 22 (22 de noviembre de 2020): 8828. http://dx.doi.org/10.3390/ijms21228828.
Texto completoRizzotto, Lara, Arianna Bottoni, Tzung-Huei Lai, Chaomei Liu, Pearlly S. Yan, Hatice G. Ozer, Rosa Lapalombella et al. "Role of Histone Deacetylase-Mediated Gene Silencing in Chronic Lymphocytic Leukemia Progression". Blood 128, n.º 22 (2 de diciembre de 2016): 2705. http://dx.doi.org/10.1182/blood.v128.22.2705.2705.
Texto completoGomis-Coloma, Clara, Sergio Velasco-Aviles, Jose A. Gomez-Sanchez, Angeles Casillas-Bajo, Johannes Backs y Hugo Cabedo. "Class IIa histone deacetylases link cAMP signaling to the myelin transcriptional program of Schwann cells". Journal of Cell Biology 217, n.º 4 (22 de febrero de 2018): 1249–68. http://dx.doi.org/10.1083/jcb.201611150.
Texto completoPsilopatis, Iason, Kleio Vrettou, Florian Nima Fleckenstein y Stamatios Theocharis. "The Impact of Histone Modifications in Endometriosis Highlights New Therapeutic Opportunities". Cells 12, n.º 9 (23 de abril de 2023): 1227. http://dx.doi.org/10.3390/cells12091227.
Texto completoHyndman, Kelly A., Malgorzata Kasztan, Luciano D. Mendoza y Sureena Monteiro-Pai. "Dynamic changes in histone deacetylases following kidney ischemia-reperfusion injury are critical for promoting proximal tubule proliferation". American Journal of Physiology-Renal Physiology 316, n.º 5 (1 de mayo de 2019): F875—F888. http://dx.doi.org/10.1152/ajprenal.00499.2018.
Texto completoMayr, Christian, Tobias Kiesslich, Sara Erber, Dino Bekric, Heidemarie Dobias, Marlena Beyreis, Markus Ritter et al. "HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer". Cancers 13, n.º 15 (31 de julio de 2021): 3862. http://dx.doi.org/10.3390/cancers13153862.
Texto completoMinisini, Martina, Emiliano Dalla, Vanessa Tolotto y Claudio Brancolini. "Abstract B014: The role of HDAC-MEF2 axis in the epigenetic control of immune tumoral microenvironment". Cancer Research 82, n.º 23_Supplement_2 (1 de diciembre de 2022): B014. http://dx.doi.org/10.1158/1538-7445.cancepi22-b014.
Texto completoShobaki, Nour, Pankaj Gaur, Rahul Nadre, Vivek Verma, Peter Ordentlich, Lei Wang, Nazli Jafarzadeh et al. "Abstract LB566: Class 1 HDAC inhibition induces antitumor immunity by NF-kB-mediated enhanced metabolic fitness and generation of unique effector function enriched memory CD8 T cell subtype". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): LB566. http://dx.doi.org/10.1158/1538-7445.am2022-lb566.
Texto completoMankidy, Rishikesh, Douglas V. Faller, Michael S. Boosalis, Regine Bohacek y Susan P. Perrine. "Mechanisms of γ-Globin Gene Promoter Activation by HBF-Inducing Short Chain Fatty Acid Derivatives." Blood 106, n.º 11 (16 de noviembre de 2005): 826. http://dx.doi.org/10.1182/blood.v106.11.826.826.
Texto completoShearstone, Jeffrey R., John H. van Duzer, Simon S. Jones y Matthew Jarpe. "Pharmacological Inhibition Of Histone Deacetylase (HDAC) 1, 2 Or 3 Have Distinct Effects On Cellular Viability, Erythroid Differentiation, and Fetal Globin (HbG) Induction". Blood 122, n.º 21 (15 de noviembre de 2013): 564. http://dx.doi.org/10.1182/blood.v122.21.564.564.
Texto completoBradbury, Charlotte A., Farhat L. Khanim, Priyanka Mehta, Rachel E. Hayden, Charles F. Craddock, Chris M. Bunce y Bryan M. Turner. "Characterisation of Histone Deacetylase (HDAC) Expression Profiles in Acute Myeloid Leukaemia: A Basis for the Development of Targeted Therapy Using Histone Deacetylase Inhibitors." Blood 104, n.º 11 (16 de noviembre de 2004): 1123. http://dx.doi.org/10.1182/blood.v104.11.1123.1123.
Texto completoYuliana, Ana, Huei-Fen Jheng, Satoko Kawarasaki, Wataru Nomura, Haruya Takahashi, Takeshi Ara, Teruo Kawada y Tsuyoshi Goto. "β-adrenergic Receptor Stimulation Revealed a Novel Regulatory Pathway via Suppressing Histone Deacetylase 3 to Induce Uncoupling Protein 1 Expression in Mice Beige Adipocyte". International Journal of Molecular Sciences 19, n.º 8 (17 de agosto de 2018): 2436. http://dx.doi.org/10.3390/ijms19082436.
Texto completoMishra, Anjali, Krista M. D. La Perle, Laura Sullivan, Gregory H. Sams, Douglas P. Curphey, Kathleen McConnell, Jun Qi et al. "Increased Expression Of IL-15 Promotes Cutaneous T-Cell Lymphomagenesis Via The Upregulation Of Histone Deacetylases: Evidence For Successful Preclinical Targeting". Blood 122, n.º 21 (15 de noviembre de 2013): 1826. http://dx.doi.org/10.1182/blood.v122.21.1826.1826.
Texto completoSoflaei, Sara Saffar, Amir Abbas Momtazi-Borojeni, Muhammed Majeed, Giuseppe Derosa, Pamela Maffioli y Amirhossein Sahebkar. "Curcumin: A Natural Pan-HDAC Inhibitor in Cancer". Current Pharmaceutical Design 24, n.º 2 (5 de abril de 2018): 123–29. http://dx.doi.org/10.2174/1381612823666171114165051.
Texto completoAlamdari, Nima, Ira J. Smith, Zaira Aversa y Per-Olof Hasselgren. "Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle". American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 299, n.º 2 (agosto de 2010): R509—R520. http://dx.doi.org/10.1152/ajpregu.00858.2009.
Texto completoKafeel, Muhammad I., Boris Avezbakiyev, Chi Chen, Yiwu Sun, Chenthil Rathnasabapathy, M. Kalavar, Zili He, Jack Burton, Stephen M. Lichter y Jen-Chin Wang. "Histone Deacetylase Activity In Chronic Lymphocytic Leukemia." Blood 116, n.º 21 (19 de noviembre de 2010): 4622. http://dx.doi.org/10.1182/blood.v116.21.4622.4622.
Texto completo